TENXIMA XT: Comprehensive Hemostatic Support with Tranexamic Acid

May 25, 2024

TENXIMA XT STOP

Tranexamic Acid, Citrus Bioflavonoids, Menadione & Tribasic Calcium Phosphate

TENXIMA XT combines Tranexamic Acid, Citrus Bioflavonoids, Menadione, and Tribasic Calcium Phosphate to provide a comprehensive hemostatic solution that not only controls excessive bleeding but also supports overall vascular health. This formulation is designed to offer synergistic benefits for patients with conditions that require enhanced hemostatic control and vascular support.

Key Ingredients in TENXIMA XT:

  1. Tranexamic Acid: An antifibrinolytic agent that helps prevent excessive bleeding by inhibiting the activation of plasminogen to plasmin, stabilizing blood clots.
  2. Citrus Bioflavonoids: Natural compounds that strengthen capillaries, reduce capillary permeability, and improve vascular health. They also possess antioxidant properties that help protect blood vessels from damage.
  3. Menadione (Vitamin K3): A synthetic form of vitamin K that plays a crucial role in blood clotting by aiding the synthesis of clotting factors in the liver.
  4. Tribasic Calcium Phosphate: A source of calcium that is essential for bone health and plays a role in the blood clotting process.

Mechanism of Action:

  • Tranexamic Acid: Works by inhibiting plasminogen activation and subsequent fibrinolysis, preventing the breakdown of fibrin clots and reducing bleeding.
  • Citrus Bioflavonoids: Improve capillary strength and vascular health, reducing the likelihood of capillary bleeding and enhancing overall circulatory health.
  • Menadione (Vitamin K3): Supports the synthesis of clotting factors necessary for blood coagulation, helping to manage and prevent excessive bleeding.
  • Tribasic Calcium Phosphate: Provides calcium, which is essential for the activation of various clotting factors and supports bone health.

Indications:

  • Heavy Menstrual Bleeding (Menorrhagia): Effective in reducing menstrual blood loss and supporting overall vascular health.
  • Post-Surgical Bleeding: Helps control bleeding after surgical procedures.
  • Nosebleeds (Epistaxis): Used to manage recurrent nosebleeds.
  • Hemophilia and Other Bleeding Disorders: Supports the management of bleeding disorders by enhancing blood clot stability.
  • General Vascular Health: Strengthens capillaries and supports overall circulatory health.

Dosage and Administration:

  • The typical dosage and duration of TENXIMA XT should be determined by a healthcare provider based on the specific condition being treated.
  • For heavy menstrual bleeding, the recommended dosage may be similar to other tranexamic acid regimens, typically taken during menstruation for up to 5 days.

Side Effects:

  • Common: Nausea, vomiting, diarrhea, abdominal pain, dizziness, and headache.
  • Less Common: Skin rash, itching, and swelling.
  • Serious: Visual disturbances, thrombosis (blood clots), severe allergic reactions, and gastrointestinal symptoms.

Precautions:

  • Thromboembolic Risk: Use with caution in patients with a history of thromboembolic disease such as deep vein thrombosis (DVT), pulmonary embolism (PE), or stroke.
  • Renal Impairment: Dosage adjustments may be necessary in patients with renal impairment to avoid accumulation and toxicity.
  • Allergies: Patients with known hypersensitivity to Tranexamic Acid, Citrus Bioflavonoids, Menadione, or Calcium Phosphate should avoid using TENXIMA XT.
  • Vitamin K Sensitivity: Monitor patients for signs of hypercoagulation if they are on other medications that affect blood clotting.

Monitoring:

  • Visual Monitoring: Monitor for any visual disturbances and discontinue use if any visual changes occur.
  • Thrombosis Monitoring: Regular monitoring for signs of thrombosis is recommended, especially in patients with a history of thromboembolic events.
  • Gastrointestinal Monitoring: Monitor for symptoms of gastrointestinal bleeding, such as black or bloody stools or vomiting blood.

Conclusion:

TENXIMA XT offers comprehensive hemostatic support by combining Tranexamic Acid, Citrus Bioflavonoids, Menadione, and Tribasic Calcium Phosphate. This multi-faceted formulation not only controls excessive bleeding but also supports vascular health and bone strength. By stabilizing blood clots, strengthening capillaries, and enhancing blood coagulation, TENXIMA XT provides a robust solution for managing conditions associated with excessive bleeding and vascular fragility. Healthcare providers should tailor dosages to individual patient needs and monitor for potential side effects to ensure safe and effective use. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH